Steven Cohen’s Ascentage Pharma AAPG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$199K Sell
12,228
-1,613
-12% -$28.4K ﹤0.01% 3499
2026
Q2
$243K Sell
13,841
-2,215
-14% -$47.2K ﹤0.01% 3455
2026
Q1
$383K Sell
16,056
-670
-4% -$16.5K ﹤0.01% 3253
2025
Q4
$439K Buy
+16,726
New +$548K ﹤0.01% 3300

Other funds holding AAPG

Steven Cohen's AAPG Position: Q3 2026 in Review

Steven Cohen reduced its Ascentage Pharma (AAPG) stake by 12% in Q3 2026, selling an estimated $28.4K and leaving 12,228 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #3499.

Steven Cohen first reported a position in AAPG in Q4 2025 and has held it in 4 quarters since. The position peaked at $439K in Q4 2025. 12 funds tracked by Wall St. Rank hold AAPG as of Q3 2026.

  • Steven Cohen held 12,228 shares of Ascentage Pharma worth $199K as of Q3 2026.
  • Steven Cohen sold 1,613 Ascentage Pharma shares in Q3 2026, an estimated $28.4K.
  • Ascentage Pharma made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3499 holding.
  • Steven Cohen first reported a position in Ascentage Pharma in Q4 2025 and has held it in 4 quarters since.
  • Steven Cohen's Ascentage Pharma position peaked at $439K in Q4 2025.
  • 12 funds tracked by Wall St. Rank held Ascentage Pharma as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.